Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles by Cindy Devone-Pacheco

Some Middle-Class Americans Worry Trump Health Subsidies Cut Will Hurt

Tim Reid and Yasmeen Abutaleb  |  October 19, 2017

PHILADELPHIA (Reuters)—Tom Westerman voted for Donald Trump in last year’s election but says he might not do so again after the president cut off billions of dollars in Obamacare subsidies to health insurance companies. “It really upset me,” said Westerman, 63, a self-described “middle-class guy” with an annual household income of about $60,000 in the…

Do Older Women Who Use Bisphosphonates Need Fewer Knee Replacements?

Reuters Staff  |  October 19, 2017

NEW YORK (Reuters Health)—The rate of knee replacement surgery among older women with knee osteoarthritis is lower in those who take bisphosphonates than in those who don’t, according to a database study. Knee osteoarthritis accounts for 97% of all knee replacement surgeries. Trials of bisphosphonates in knee osteoarthritis have yielded conflicting results. To learn more,…

Keeping the Pressure on Congress: ACR Opposes Medicare Payment Adjustment Plan, Executive Order

Angus Worthing, MD, FACP, FACR  |  October 19, 2017

Greetings, advocates! Here’s a brief, interim hodgepodge of updates to keep you posted on government advocacy before the deluge of information swamps you in San Diego. The Next Big Thing: Part B Drug Reimbursements Medicare currently plans to adjust reimbursement of doctors in the MIPS program in 2019, not only based on E/M office services,…

New RheumPAC Investor Portal Unveiled

Harry L. Gewanter, MD, FAAP, FACR  |  October 19, 2017

This is my fifth year serving on RheumPAC, and some of the questions that I repeatedly have been asked include: Why can’t I divide my investments into automatic monthly payments? Why can’t I invest from my phone? Why can’t I schedule an annual contribution so I don’t forget to invest? Why can’t I look up…

White House Says Trump Opposes Bipartisan Senate Deal on Obamacare

Yasmeen Abutaleb and Amanda Becker  |  October 18, 2017

WASHINGTON (Reuters)—A bipartisan deal from two U.S. senators to stabilize Obamacare by restoring subsidies to health insurers ran into trouble on Wednesday with the White House saying President Donald Trump now opposes it and a senior Senate Republican saying it has stalled. House of Representatives Speaker Paul Ryan also signaled opposition to the deal announced…

Health Insurer Anthem Takes Pharmacy Business in House, Taps CVS to Help

Reuters Staff  |  October 18, 2017

(Reuters)—Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding that had deteriorated into lawsuits over terms. Anthem, which sued the pharmacy benefit manager last year over claims of being overcharged by $3 billion annually, said it…

U.S. Senate Backers of Obamacare Deal Seek Support but Prospects Unclear

Yasmeen Abutaleb and Richard Cowan  |  October 18, 2017

WASHINGTON (Reuters)—Proponents of a bipartisan deal struck by two U.S. senators to stabilize Obamacare sought on Wednesday to win Republican support for the measure, which would restore subsidies to health insurers that President Donald Trump has scrapped. With 2018 health insurance markets facing potential chaos, Republican Senator Lamar Alexander and Democratic Senator Patty Murray were…

Trump Healthcare Order Could Face Strong Legal Objections

Brendan Pierson and Nate Raymond  |  October 12, 2017

(Reuters)—U.S. President Donald Trump’s expected plan to let Americans buy insurance across state lines could violate federal law governing employee benefit plans and will almost certainly be challenged in court, several legal experts said. Trump said on Tuesday he would likely sign an executive order this week allowing people to cross state lines to obtain…

Frustrated by Congress, Trump Signs Order to Weaken Obamacare

Yasmeen Abutaleb and Jeff Mason  |  October 12, 2017

WASHINGTON (Reuters)—President Donald Trump on Thursday signed an order to make it easier for Americans to buy bare-bones health insurance plans, using his presidential powers to undermine Obamacare after fellow Republicans in Congress failed to repeal the 2010 law. Trump issued the executive order aimed at letting small businesses band together across state lines to…

Senator McCaskill Drafts Bill in Response to Allergan Patent Maneuver

Michael Erman  |  October 5, 2017

NEW YORK (Reuters)—Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent. Drugmaker Allergan Plc made a deal to transfer some of its patents to a Native American tribe two weeks ago in order…

  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 28
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences